{
  "docId": "019de073-a38b-741c-ac33-1ee77869cf6c",
  "docSlug": "1556a4546991601fbfe098864d52433b",
  "documentTitle": "ATAI | Investor Presentation Deck | 36 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 36,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide uses a split-view layout: a list of past achievements on the left and a timeline of future events on the right.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a38b-741c-ac33-1ee77869cf6c/8",
  "deckHref": "/decks/019de073-a38b-741c-ac33-1ee77869cf6c",
  "deckJsonHref": "/decks/019de073-a38b-741c-ac33-1ee77869cf6c.json",
  "deckAnchorHref": "/decks/019de073-a38b-741c-ac33-1ee77869cf6c#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.35,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Timeline showing H1 2022, H2 2022, H1 2023, H2 2023, H1 2024 with associated R&D milestones.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "213c6314-ea5e-41f5-8c6e-a1ef9b37211f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.28,
        "x": 0.05,
        "y": 0.39
      },
      "kind": "list",
      "text": "Positive topline results in Phase 2b trial of COMP360 in TRD patients; Successful outcomes of Phase 2a proof-of-mechanism trial of RL-007 in CIAS patients; Successful outcomes of Phase 1 trial of PCN-101; Collaboration agreement with Otsuka; Acquired 6 new companies.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "017158b7-aefa-47df-bfe7-ae7ca11b14fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.35,
        "y": 0.245
      },
      "kind": "title",
      "text": "Anticipated catalysts across 2022, 2023 & 2024",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ba7d6ed-55d4-4ec7-a603-686ccc1d8b0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "We will build on recent success by delivering several meaningful R&D catalysts anticipated across our key programs in 2022, 2023 & 2024",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5bb51adc-56de-47da-b08d-f15c1674757b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.05,
        "y": 0.245
      },
      "kind": "title",
      "text": "Milestone highlights in 2021",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7a6e01f-fc93-4e65-93d9-79e21f6e6fbf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "c72f28e9-3453-4129-87ba-6b64f87cafb3",
      "evidence": "The slide uses a timeline-based visualization to map future R&D milestones.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 9,
      "from": 8,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "e517bb24-eaa5-4a74-941e-b0e791cb448a",
      "evidence": "Slides 8 and 9 create a loop by presenting recent success and future plans",
      "position": 1,
      "objective": "Explain why now is the right time for atai Life Sciences",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}